Heme

Study Name: CSL624_2001

• Cancer Stage: N/A
• Key Inclusion: HFE+ HH
• Description: CSL624_2001 / A Phase 2, Multicenter, Randomized, Placebo-controlled, Double-blind Study of Vamifeport in Adult Subjects with HFE-related Hereditary Hemochromatosis
• Study Number: N/A
• NCT#: NCT07332091